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Abstract
In the acute medicine, fluid therapy is a common intervention. Clinicians may have differ-
ent preferences in prescribing the fluids—the type, the volume and rate, and the monitor-
ing of response—but there is a growing argument in the literature for a more consistent 
and evidence-based approach to these prescriptions. This coincides with the call to treat 
fluids as drugs and to strategize the fluid management of individual patients. A good 
start toward observing this call will be an appreciation of the underlying physiology. The 
hemodynamic, biochemical, and microcirculatory responses to fluid therapy will influ-
ence the end-organ and clinical effects. In translating these physiological insights into 
practice, recent studies in several acute cohorts like trauma, sepsis, and postoperative 
and intensive care offer valuable guides. With all this in mind, the chapter aims to review 
the optimal approach to fluid therapy in the acute setting, from the understanding of the 
relevant basic sciences to the practice at the bedside.
Keywords: intravenous infusions, crystalloid solutions, colloids, emergency medicine, 
critical care
1. Introduction
Majority of patients, in the early and immediate phase of their presentations to the hospital, 
will require fluid therapy. These fluids are given for various indications, from hemodynamic 
instability to the delivery of medications [1]. The clinical scenarios that demand the adminis-
tration of fluids in the acute phase of these patients’ stay in the hospital are often complex, yet 
the task in deciding the fluid regimen is often delegated to junior staff who may lack the nec-
essary insight and experience [2]. Such attitude is compounded by the inadequate knowledge, 
among the doctors, on the essentials of intravenous fluids like the electrolyte components [3].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Intravenous fluids are drugs, and like other drugs, there are potential complications. In the 
acute setting where these fluids are commonplace, it is imperative that the practice aims at 
administering the right patient the right fluids, at the right volume and rate, with the right 
overall fluid balance.
2. Fluids and physiology
Water is the most important and abundant element of the human body, and the physiology 
that surrounds it is extensive. The following principles are at best, the foundations toward an 
informed fluid practice.
2.1. The body fluid compartments
Water, on average, makes up 60% of the total body weight. The percentage will vary depend-
ing on the gender and the fat content in the body. There is an inverse correlation between the 
water content of the body and the fat content as adipose tissue contains less water than lean 
tissue. This explains why women have lower percentages of water than men as they have a 
higher percentage of adipose tissue.
Water in the body is functionally distributed among the two main body fluid compartments, 
the intracellular fluid (ICF) and the extracellular fluid (ECF) (Figure 1). The ICF constitutes 
approximately two-thirds of the total body water or 40% of the body weight and the ECF the 
remaining one-third or 20% of the body weight [4]. Water crosses between the ICF and the 
ECF through aquaporin channels in the cell membrane to attain osmotic equilibrium. The cell 
Figure 1. The distribution of total body water.
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membrane also contains active pumps and transporters that distribute individual solutes, 
including electrolytes. These electrolytes account for the effective osmolality (tonicity) that 
governs the water movement. The mechanisms of these electrolyte movements are further 
defined by the Gibbs-Donnan effect of the nondiffusible large anions like protein. The end 
results are an ICF compartment with potassium (K+) as the predominant ion and an ECF com-
partment with sodium (Na+) and chloride (Cl−) as the predominant ions [5].
The ECF is further divided into the interstitial fluid and the plasma compartments, the two 
separated by the capillary wall. Except for plasma proteins and blood cells, the pores on the 
capillary wall permit the flux of water and small solutes. This contributes to the two compart-
ments having almost similar electrolyte composition with only small differences contributed 
by the Gibbs-Donnan effect of the plasma proteins. By volume, these plasma proteins con-
stitute 7% of the plasma volume with the remaining 93% plasma water. As a side note, these 
proteins are solids in the plasma, and the changes in their plasma load will affect the water-
based measurements of plasma electrolyte concentrations [6].
2.2. The body fluid regulation
A complex interaction of regulatory mechanisms from different organs helps the body to 
maintain an effective fluid volume in different circumstances. The key pathway that underpins 
this volume regulation is the hormonally mediated renin-angiotensin II-aldosterone-system 
(RAAS), with the faster neutrally mediated baroreceptor reflex contributing an indirect role 
through its interplay of the pressure regulation. In the context of the fluid therapy scope of the 
chapter, the RAAS will be elaborated below.
The RAAS pathway is activated by a decrease in the renal perfusion pressure, detected by 
the juxtaglomerular apparatus (JGA) (Figure 2). In the JGA, the reduced renal perfusion 
stimulates the granular cells of the afferent arteriole to secrete the proteolytic enzyme 
renin through a direct intrarenal baroreceptor activity and detection of reduced sodium 
chloride concentrations by the macula densa in the wall of the ascending limb of the loop 
Figure 2. The juxtaglomerular apparatus.
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of Henle. Besides these mechanisms, the renin release is also controlled by renal sympa-
thetic nerves and angiotensin II.
Renin as an enzyme will then catalyze the conversion of angiotensinogen, a large protein 
produced in the liver, to angiotensin I, a decapeptide. This is the rate-limiting step of the 
RAAS pathway (Figure 3). Angiotensin I has little biologic activity apart from being the pre-
cursor to angiotensin II. Its conversion to angiotensin II involves the removal of two amino 
acid moieties by the angiotensin-converting enzyme (ACE). ACE is primarily located in the 
pulmonary capillaries, but it is also found in the kidney epithelial cells.
The ultimate objective of the RAAS, through the activities of angiotensin II and aldosterone as 
summarized in Figure 3, is the preservation of effective fluid volume and pressure. The RAAS 
demonstrates the strong interconnection between the body fluid and electrolytes in maintain-
ing the fluid homeostasis. In the acute setting, this interconnection is very relevant given the 
frequent alterations of the electrolyte contents of the body in the acute phase of illness. The 
assessment of electrolytes in the acute patients should, therefore, be comprehensive and extend 
beyond the laboratory results. For example, the assessment should also consider the potential 
electrolyte losses from the gastrointestinal tract, a common organ affected in acute illnesses [7].
2.3. The microcirculation model
The classic microcirculation model, based on the semipermeability of the capillary and post-
capillary venule walls, and the presence of hydrostatic and oncotic pressure gradients across 
these walls had for long described the flux of fluids and electrolytes between the plasma 
and the interstitial fluid [8, 9]. The identification of the endothelial glycocalyx layer, a web 
of membrane-bound glycoproteins and proteoglycans on the luminal side of endothelial 
cells, has now challenged the classic model [10, 11]. The colloid oncotic pressure from the 
sub-glycocalyx space is a key determinant of the trans-capillary flow. The disruption to the 
integrity of the glycocalyx layer, or the “leakiness,” in a number of acute situations like sepsis 
[12], trauma, and postsurgery, has been attributed to the development of interstitial edema 
Figure 3. The renin-angiotensin II-aldosterone-system (RAAS).
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in various organs of the body (Figure 4). Appreciation of the dynamics of glycocalyx in the 
microcirculation of the acute cohort of patients will be integral in their fluid resuscitation and 
in future fluid research in such population [13, 14].
3. The types of fluids
The history of intravenous fluids began during the cholera pandemic in Europe in the 1830s. The 
success of Thomas Latta in using a saline solution to resuscitate dying cholera patients paved the 
way for the widespread use of intravenous fluids and the research to refine their contents [15]. 
The early milestones in intravenous fluid therapy included the first experiment with albumin 
in 1834 [16] and the attempt by Sydney Ringer to develop a physiological solution for cardiac 
contractility with his Ringer’s solution in 1876 [17]. Ringer’s solution was modified by Alexis 
Hartmann in 1932 by including lactate to help overcome the acidosis in dehydrated pediatric 
patients [18]. The gelatins and other solutions with larger molecules only broke into the scene 
during the Second World War [19], although the first study in humans was performed in 1915 
[20]. It is interesting that the history behind the most common type of fluids used, the 0.9% saline, 
is unclear. The present-day 0.9% saline, often called the “normal saline,” has far higher sodium 
and chloride concentrations than Latta’s 1832 saline solution. The only possible connection to 
0.9% saline in the history was the in vitro studies of Hamburger in the 1890s that described 0.9% 
NaCl as an “indifferent solution” in which erythrocytes were least likely to lyse [21, 22].
From the above breakthroughs, the science of intravenous fluids has grown progressively, 
especially in the last couple of decades. Whether medicine will find an answer to the ideal 
intravenous fluid will be debatable, but more evidence has emerged in the comparison 
between the different types of fluids available.
3.1. Crystalloids
Crystalloids are solutions containing salts in the form of electrolytes and small molecules. The 
composition of commonly available crystalloids is given in Table 1.
Figure 4. The endothelial glycocalyx layer in healthy, equilibrium state (A) and damaged, leaky state (B) that leads to 
interstitial edema.
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Based on their differing compositions, crystalloids have been divided into saline solutions and 
balanced solutions. Saline solutions, chiefly the 0.9% NaCl solutions, are differentiated from 
the rest of crystalloids by their high contents of sodium and chloride. These concentrations 
of 150 mmol/L, especially for chloride, are much higher than the plasma concentrations. The 
0.9% saline has thus been described as supra-physiological, and the name “normal saline” has 
been put to question [23, 24]. Balanced solutions, on the other hand, are other solutions like 
Hartmann’s, Plasmalyte 148®, and Sterofundin® that contains more closely resemble human 
plasma concentrations. These solutions achieve lower sodium and chloride concentrations 
through the addition of other electrolytes and buffers like lactate and acetate.
The debate is ongoing as to which will be the better choice for the acute population of patients, 
saline or balanced solutions. While saline is cheap and is still the most commonly used crys-
talloid in the world, there are significant concerns with its effect on acid-base balance and 
kidney function. The high chloride contents of saline contribute to the hyperchloremic or 
strong ion acidosis [25–27], and this has been well shown in different studies in different acute 
populations [28–30]. Given that acidosis is a common biochemical presentation in the acute 
setting, such acidosis could confuse patients’ assessment. This has made a case for suggesting 
balanced solutions as the fluid of choice, even when saline has always been the conventional 
prescription like in diabetic ketoacidosis [31, 32].
On the other hand, the potential risk of acute kidney injury (AKI) from the use of saline is a 
main research agenda. Changing the intravenous fluid practice from chloride-rich fluids (0.9% 
saline, 4% succinylated gelatin, or 4% albumin) to chloride-restrictive fluids (Hartmann’s solution, 
Plasma-Lyte 148, and 20% albumin) had been shown to reduce the incidence of AKI in the inten-
sive care and emergency department populations in a single-center, open label sequential trial 
Plasma 0.9% NaCl Hartmann’s Plasmalyte 148® Sterofundin®
Sodium 140 150 131 140 140
Potassium 5 0 5 5 4
Chloride 100 150 111 98 127
Calcium 2.2 0 2 0 2.5
Magnesium 1 0 1 1.5 1
Bicarbonate 24 0 0 0 0
Lactate 1 0 29 0 0
Acetate 0 0 0 27 24
Gluconate 0 0 0 23 0
Maleate 0 0 0 0 5
Real osmolality 287 286 254 273 287
Plasma-Lyte 148®: Baxter International, Deerfield, IL, USA; Sterofundin®: B Braun, Melsungen, Germany. All concen-
trations in mmol/L; osmolality in mosmol/kg.
Table 1. The composition of commonly used crystalloids.
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[33–35]. Among the explanations suggested for the higher AKI incidence with the chloride-rich 
fluids like saline is the renal vasoconstrictive response to the high chloride delivery to the macula 
densa of JGA, a mechanism similar to the regulatory tubuloglomerular feedback [36, 37]. Similar 
trends of results implicating saline with AKI have been repeated in large retrospective trials [38, 
39]. However, the only three large randomized trials comparing saline with balanced solutions to 
date have shown inconsistent results. These cluster randomized trials either showed no difference 
in renal outcomes [40] or a significant increase in major adverse kidney events within 30 days in 
the saline group for both the intensive care and emergency department populations [41, 42].
While large multicenter randomized controlled trials are ongoing to provide stronger evi-
dence on the issue of saline [43, 44], there has been a notable shift in clinical practice with an 
increasing use of the balanced solutions [45]. 0.9% saline, nonetheless, remains the fluid of 
choice for patients with metabolic acidosis, hyponatremia, and traumatic brain injury, the 
latter attributed to its relatively high osmolality.
3.2. Colloids
Colloid solutions are characterized by the large molecules suspended in carrier solutions that 
would also contain electrolytes. The colloid osmotic pressure or oncotic pressure generated 
by these large molecules helps to retain fluid in the intravascular space longer. The composi-
tion of the commonly available colloids is in Table 2.
The volume effect of colloid, when compared to crystalloid, has traditionally been thought 
to be at a 1:3 ratio. This gives colloid a perceived advantage in reducing the volume of fluid 
Plasma Gelofusine® Albumex®4 Albumex®20 Voluven® (HES 6% 
130/0.4)
Sodium 140 154 140 48-100 154
Potassium 5 0 0 0 0
Chloride 100 125 128 19 154
Calcium 2.2 0 0 0 0
Magnesium 1 0 0 0 0
Bicarbonate 24 0 0 0 0
Lactate 1 0 0 0 0
Acetate 0 0 0 0 0
Malate 0 0 0 0 0
Octanoate 0 0 6.4 32 0
Real osmolality 287 271 260 130 298
HES: hydroxyethyl starch. Gelofusine®: B Braun, Melsungen, Germany; Albumex®: CSL Limited, Victoria, Australia; 
Voluven®: Fresenius-Kabi, Bad Homburg, German. All concentrations in mmol/L; osmolality in mosmol/kg.
Table 2. The composition of commonly used colloids.
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infused during resuscitation. However, data from recent large multicenter trials on the use 
of different types of colloids suggested a smaller colloid: crystalloid ratio, between 1:1.1 and 
1:1.6 [46–49]. The finding of smaller volume effect advantage from colloid than previously 
thought adds to the predominant concern on the use of colloid—its effects on the kidney.
Strong evidence emerged in the last decade demonstrating a significant association between 
the risk of renal dysfunction, measured as AKI, and the need for renal replacement therapy, 
with the use of hydroxyethyl starch in the acute population of sepsis and intensive care [46, 47]. 
There are also doubts from observational data on the renal safety of another choice of colloid, 
the gelatins, in the septic population [50, 51]. The hyperoncotic albumin solutions (20–25%), on 
the other hand, have been associated with increased risk of renal events when used in cardiac 
surgery [52] and in patients in shock [53].
Besides these renal effects, colloids are more expensive than crystalloids, and there has been 
an absence of their clinical superiority over crystalloids in the mortality outcome of studies on 
different acute populations [49, 54, 55]. All these lead to the call for caution in the use of col-
loids. The recent Surviving Sepsis Guidelines, for example, strongly recommend against the 
use of hydroxyethyl starches and place albumin and gelatins as a second choice to crystalloids 
in sepsis fluid resuscitation [56].
4. Delivering fluid therapy
Following an evidence-informed choice of fluid, the next set of decisions will be equally cru-
cial: how to administer the fluid, how to measure the patient’s response to the fluid, and how 
much fluid should be given. Strategizing intravenous fluid delivery to an acute patient should 
include a well thought-out plan for these three important elements.
4.1. Resuscitation and the fluid challenge
A key aim of the fluid resuscitation in the acute setting is to exert a hemodynamic impact, 
increasing the venous return and the stroke volume. To achieve this, the concept of fluid chal-
lenge or fluid bolus was introduced almost four decades ago [57, 58]. The fluid challenge is a 
targeted administration approach through the delivery of a small amount of fluid over a short 
period of time, with an assessment of the fluid responsiveness [59].
The administration of fluid challenge has been one of the most diverse practices in fluid ther-
apy. Recent attempts at identifying the global patterns in fluid challenge have provided valu-
able information. A global inception cohort study on fluid challenge involving 2213 patients 
across ICUs in 46 countries revealed a median amount of fluid challenge volume of 500 ml, a 
median time of 24 min, a median rate of fluid administration of 1000 ml/h, and a predominant 
choice of crystalloids [60]. Interestingly, categorizing patients as fluid responsive, non-fluid 
responsive, or uncertain fluid responsive did not make any difference to the receipt of further 
fluid administration in this study. In another study on the worldwide fluid challenge prac-
tices, involving 3138 intensive care specialists from 30 countries, more than 80% respondents 
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defined the fluid bolus therapy as delivery of more than 250 mL of either colloid or crystalloid 
fluid over less than 30 minutes, with crystalloids the most acceptable [61]. These numbers 
only reflect the majority views on the fluid challenge and must be interpreted in the context 
of the other aspects of an acute fluid strategy—the fluid responsiveness and the fluid balance.
4.2. Fluid responsiveness
Clinical assessment is always an integral component of any fluid therapy approach. Identi-
fying body volume repletion and the likelihood to respond to fluid resuscitation should begin 
with the background history and elicitation of signs of volume deficits, from the peripheral 
temperature gradient and capillary refill time [62] to the tachycardia, decreased mean arte-
rial pressure, and oliguria. However, reliance on these clinical signs alone for assessment of 
volume status and responsiveness could be misleading [63–65]. For instance, an increase in 
the mean arterial pressure following a fluid challenge could be a result of the changes in the 
arterial vascular tone rather than a true increase in cardiac output.
Beyond clinical signs, the indices of fluid responsiveness—both static and dynamic—have 
been extensively studied. The static index of central venous pressure (CVP), arguably the most 
commonly used measure of fluid responsiveness, has long been shown to have no meaningful 
relationship to fluid volume and should be abandoned [66]. Similarly, the more invasive static 
index measurement of pulmonary artery occlusion pressure (PAOP) has its limitations and 
does not predict fluid responsiveness [67, 68].
The dynamic indices of fluid responsiveness work on the basis of inducing a change in pre-
load and following up the effects on stroke volume and cardiac output [69]. There are different 
versions of these dynamic measurements with many evolving around the respiratory varia-
tion of hemodynamic indices. Examples include the pulse pressure variation (PPV), the pulse 
contour-derived stroke volume, the inferior vena cava (IVC) parameters assessed by ultra-
sonography, and the descending aortic blood flow assessed by esophageal Doppler [70–75]. 
There are, however, limitations to the observations of these respiratory variations. Some of 
these are of practical significance, like the need for tidal volumes of >7 ml/kg, the absence of 
spontaneous ventilatory efforts, and the absence of arrhythmia.
An approach to assessment of fluid responsiveness that is not affected by the practical ventila-
tory limitations above is the passive leg raising, PLR [76]. The postural change in PLR trans-
fers around 300 mL of venous blood from the lower body to the heart. The advantage of this 
is it is an endogenous fluid challenge that is rapidly reversible [77]. To date, the PLR has been 
deemed as the most reliable measure of fluid responsiveness [78], although an increase in the 
intra-abdominal pressure or pain could give a false-negative result [79].
It is important to recognize that fluid responsiveness does not necessarily mean that fluid 
challenges must be given. It also does not mean that patients should be receiving fluid 
challenges until they are no longer fluid responsive. The hemodynamic benefits of the 
fluid boluses should be weighed against the risks of accumulating positive fluid balance, 
with a strong consideration of the use of vasopressors like noradrenaline to improve 
organ perfusion [80].
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4.3. The importance of fluid balance
Fluid accumulation in the acute setting is a frequent event. While everything is geared toward 
early and aggressive fluid resuscitation, as it should be, less emphasis is given toward the 
risks associated with fluid accumulation and overload. As fluid overload is shown to con-
tribute to poorer outcomes in different acute populations [81–84], it becomes imperative to 
achieve the right balance between overcoming hypovolemia and organ hypoperfusion and 
avoiding the dangers of fluid overload [85].
A common quantitative definition of fluid overload in the literature is a percentage fluid 
accumulation of >10%, determined by dividing the cumulative fluid balance in liter by the 
patient’s baseline body weight and multiplying by 100% [86, 87]. This is, however, on the 
assumption that the patient is volume depleted on admission to the acute unit, which is 
not necessarily the case as some patients have already been accumulating fluid by then. 
The negative effects of the excess fluid have been shown in various organ systems. In a 
large RCT, higher cumulative fluid balance was associated with longer mechanical ventila-
tion duration and length of ICU stay and without reducing the incidence of shock and the 
need for renal replacement therapy [88]. In managing intra-abdominal hypertension and 
abdominal compartment syndrome, poorer outcomes have been attributed to fluid over-
load [89, 90], a phenomenon linked to capillary leak and tissue edema. While fluid is often 
aggressively given to prevent AKI, the association between fluid overload and poorer renal 
outcomes has been evident [86, 91, 92], prompting questions on the cause-effect relationship 
between fluid overload and AKI [93].
A comprehensive fluid strategy will require a close monitoring of the fluid balance. In this 
context, a mindset of fluids as drugs will promote careful considerations of the indications 
and the doses of the fluids, recognizing that more is not always better.
5. Conclusion
In conclusion, fluid therapy in the acute setting is a challenging and complex task for the clini-
cians. Two areas that are beyond the scope of the chapter—the specific needs of the different 
subpopulations of acute patients and the different access to resources at different locations of 
practice—further add to the complexity. Emerging evidence on various facets of fluid therapy 
has helped to offer some consistency in approach in what has been a very diverse practice. 
The underpinning principle should be fluids are drugs that must be chosen and prescribed 
correctly, as wrong choice and doses lead to adverse effects.
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